Literature DB >> 28515908

Renal manifestations of primary mitochondrial disorders.

Josef Finsterer1, Fulvio Alexandre Scorza2.   

Abstract

The aim of the present review was to summarize and discuss previous findings concerning renal manifestations of primary mitochondrial disorders (MIDs). A literature review was performed using frequently used databases. The study identified that primary MIDs frequently present as mitochondrial multiorgan disorder syndrome (MIMODS) at onset or in the later course of the MID. Occasionally, the kidneys are affected in MIDs. Renal manifestations of MIDs include renal insufficiency, nephrolithiasis, nephrotic syndrome, renal cysts, renal tubular acidosis, Bartter-like syndrome, Fanconi syndrome, focal segmental glomerulosclerosis, tubulointerstitial nephritis, nephrocalcinosis, and benign or malign neoplasms. Among the syndromic MIDs, renal involvement has been most frequently reported in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome, Kearns-Sayre syndrome, Leigh syndrome and mitochondrial depletion syndromes. Only in single cases was renal involvement also reported in chronic progressive external ophthalmoplegia, Pearson syndrome, Leber's hereditary optic neuropathy, coenzyme-Q deficiency, X-linked sideroblastic anemia and ataxia, myopathy, lactic acidosis, and sideroblastic anemia, pyruvate dehydrogenase deficiency, growth retardation, aminoaciduria, cholestasis, iron overload, lactacidosis, and early death, and hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis syndrome. The present study proposes that the frequency of renal involvement in MIDs is probably underestimated. Diagnosis of renal involvement follows general guidelines and treatment is symptomatic. Thus, renal manifestations of primary MIDs require recognition and appropriate management, as they determine the outcome of MID patients.

Entities:  

Keywords:  mtDNA mutation; oxidative phosphorylation; renal dysfunction; renal tubular acidosis; respiratory chain

Year:  2017        PMID: 28515908      PMCID: PMC5431253          DOI: 10.3892/br.2017.892

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  86 in total

1.  An autopsy case of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) with intestinal bleeding in chronic renal failure.

Authors:  Akira Mima; Fumihiko Shiota; Takeshi Matsubara; Noriyuki Iehara; Taro Akagi; Hideharu Abe; Kojiro Nagai; Motokazu Matsuura; Taichi Murakami; Seiji Kishi; Toshikazu Araoka; Fumi Kishi; Naoki Kondo; Reiko Shigeta; Kazuhiro Yoshikawa; Toru Kita; Toshio Doi; Atsushi Fukatsu
Journal:  Ren Fail       Date:  2011-06-01       Impact factor: 2.606

2.  Mitochondrial Disorders May Mimic Amyotrophic Lateral Sclerosis at Onset.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Sultan Qaboos Univ Med J       Date:  2016-02-02

3.  Renal cell carcinoma in a pediatric patient with an inherited mitochondrial mutation.

Authors:  Surasak Sangkhathat; Takeshi Kusafuka; Akihiro Yoneda; Seika Kuroda; Yukichi Tanaka; Mio Tanaka; Norio Sakai; Masahiro Fukuzawa
Journal:  Pediatr Surg Int       Date:  2005-10-20       Impact factor: 1.827

4.  Focal segmental glomerulosclerosis associated with mitochondrial cytopathy.

Authors:  L M Doleris; G S Hill; P Chedin; D Nochy; C Bellanne-Chantelot; T Hanslik; J Bedrossian; S Caillat-Zucman; J Cahen-Varsaux; J Bariety
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

5.  Kearns-Sayre syndrome associated with de Toni-Debré-Fanconi syndrome due to cytochrome-c-oxidase (COX) deficiency.

Authors:  A Berio; A Piazzi
Journal:  Panminerva Med       Date:  2001-09       Impact factor: 5.197

Review 6.  Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options.

Authors:  Ayman W El-Hattab; Fernando Scaglia
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

7.  A novel homozygous YARS2 mutation causes severe myopathy, lactic acidosis, and sideroblastic anemia 2.

Authors:  Junya Nakajima; Tuba F Eminoglu; Goksel Vatansever; Mitsuko Nakashima; Yoshinori Tsurusaki; Hirotomo Saitsu; Hisashi Kawashima; Naomichi Matsumoto; Noriko Miyake
Journal:  J Hum Genet       Date:  2014-01-16       Impact factor: 3.172

8.  Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutation.

Authors:  A Saada; A Shaag; S Arnon; T Dolfin; C Miller; D Fuchs-Telem; A Lombes; O Elpeleg
Journal:  J Med Genet       Date:  2007-09-14       Impact factor: 6.318

9.  Diabetes in pediatric patients with Kearns-Sayre syndrome: clinical presentation of 2 cases and a review of pathophysiology.

Authors:  Josephine Ho; Danièle Pacaud; Maja Rakic; Aneal Khan
Journal:  Can J Diabetes       Date:  2014-08       Impact factor: 4.190

10.  Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion.

Authors:  Alice Bourdon; Limor Minai; Valérie Serre; Jean-Philippe Jais; Emmanuelle Sarzi; Sophie Aubert; Dominique Chrétien; Pascale de Lonlay; Véronique Paquis-Flucklinger; Hirofumi Arakawa; Yusuke Nakamura; Arnold Munnich; Agnès Rötig
Journal:  Nat Genet       Date:  2007-05-07       Impact factor: 38.330

View more
  23 in total

1.  Nephrotic syndrome and mitochondrial disorders: answers.

Authors:  Julie Bernardor; Camille Faudeux; Anabelle Chaussenot; Corinne Antignac; Alice Goldenberg; Marie Claire Gubler; Nicole Wagner; Etienne Bérard
Journal:  Pediatr Nephrol       Date:  2019-03-12       Impact factor: 3.714

2.  Case Report: Optic Atrophy and Nephropathy With m.13513G>A/MT-ND5 mtDNA Pathogenic Variant.

Authors:  Valentina Barone; Chiara La Morgia; Leonardo Caporali; Claudio Fiorini; Michele Carbonelli; Laura Ludovica Gramegna; Fiorina Bartiromo; Caterina Tonon; Luca Morandi; Rocco Liguori; Aurelia Petrini; Rachele Brugnano; Rachele Del Sordo; Carla Covarelli; Manrico Morroni; Raffaele Lodi; Valerio Carelli
Journal:  Front Genet       Date:  2022-06-03       Impact factor: 4.772

3.  The Spectrum of Renal Abnormalities in Mitochondrial Disorders Is Broad.

Authors:  Josef Finsterer
Journal:  Kidney Int Rep       Date:  2022-05-19

4.  Galloway-Mowat Syndrome Type 3 Caused by OSGEP Gene Variants: A Case Report and Literature Review.

Authors:  Suhua Xu; Lan Hu; Lin Yang; Bingbing Wu; Yun Cao; Rong Zhang; Xin Xu; Haiyan Ma; Wenhao Zhou; Guoqiang Cheng; Peng Zhang; Liyuan Hu
Journal:  Front Pediatr       Date:  2022-06-17       Impact factor: 3.569

5.  Nephrological and urological complications of homozygous c.974G>A (p.Arg325Gln) OSGEP mutations.

Authors:  Peter Zhan Tao Wang; Chitra Prasad; Carmen Inés Rodriguez Cuellar; Guido Filler
Journal:  Pediatr Nephrol       Date:  2018-08-23       Impact factor: 3.714

6.  Apoptosis-inducing factor plays a role in the pathogenesis of hepatic and renal injury during cholestasis.

Authors:  Vahid Ghanbarinejad; Akram Jamshidzadeh; Bahman Khalvati; Omid Farshad; Huifeng Li; Xiong Shi; Yuanyu Chen; Mohammad Mehdi Ommati; Reza Heidari
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-02-01       Impact factor: 3.000

7.  Mitochondrial cardioencephalopathy due to a COQ4 mutation.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Mol Genet Metab Rep       Date:  2017-07-13

8.  Kidney epithelial targeted mitochondrial transcription factor A deficiency results in progressive mitochondrial depletion associated with severe cystic disease.

Authors:  Ken Ishii; Hanako Kobayashi; Kensei Taguchi; Nan Guan; Andraia Li; Carmen Tong; Olena Davidoff; Pamela V Tran; Madhulika Sharma; Navdeep S Chandel; Meghan E Kapp; Agnes B Fogo; Craig R Brooks; Volker H Haase
Journal:  Kidney Int       Date:  2020-11-04       Impact factor: 10.612

9.  Response to the Letter to the Editor by Finsterer and Zarrouk-Mahjoub in Clin Nephrol Case Stud. 2018; 6: 1.

Authors:  Kenneth Lim; David Steele; Andrew Fenves; Ravi Thadhani; Eliot Heher; Amel Karaa
Journal:  Clin Nephrol Case Stud       Date:  2018-01-16

10.  Comment to: Focal segmental glomerulosclerosis associated with mitochondrial disease by Lim et al. in Clin Nephrol Case Stud. 2017; 5: 20-25.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Clin Nephrol Case Stud       Date:  2018-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.